|
Volumn 2, Issue 2, 2001, Pages
|
Preventive health program aims to reduce cost, incidence of breast cancer.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
TAMOXIFEN;
ARTICLE;
BREAST TUMOR;
ECONOMICS;
EVIDENCE BASED MEDICINE;
FEMALE;
HEALTH INSURANCE;
HEALTH SERVICE;
HEALTH SERVICES RESEARCH;
HUMAN;
INCIDENCE;
NATIONAL HEALTH INSURANCE;
ORGANIZATION AND MANAGEMENT;
PREMEDICATION;
PREVENTIVE HEALTH SERVICE;
UNITED STATES;
ANTINEOPLASTIC AGENTS, HORMONAL;
BLUE CROSS;
BLUE SHIELD;
BREAST NEOPLASMS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HEALTH SERVICES NEEDS AND DEMAND;
HUMANS;
INCIDENCE;
MINNESOTA;
ORGANIZATIONAL CASE STUDIES;
PREMEDICATION;
PREVENTIVE HEALTH SERVICES;
TAMOXIFEN;
|
EID: 84921440507
PISSN: None
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|